A Cooperative group committed to lymphoma research

Early-phase clinical trials

Platform for early-phase clinical trials

A platform for conducting Phase I/IIa clinical trials has been set up that performs studies, including first-in-human studies, in collaboration with industrial partners, INCa, and the American National Cancer Institute (NCI). It brings together the capabilities of a dedicated LYSARC team, as well as those of a network of LYSA centres of expertise, in particular the INCa-accredited early-phase centres, otherwise known as “CLIP2” centres. There are between 8 and 12 LYSA centres for Phase I trials and between 20 and 30 centres for Phase IIa trials.

LYSA’s Missions

Learn more
lymphome

What is Lymphoma?

Learn more

LYSA Research

Learn more

Take Part in a Clinical Trial

Learn more

The LYSA's Centers

Learn more

Support Research

Learn more